presents with severe, persistent abdominal pain radiating to the back
1 Total weight loss varied among groups, with semaglutide monotherapy-treated participants losing 23.0 lbs (10.4% body weight reduction), those taking the lower-dose combination losing 21.6 lbs (9.9%), and participants receiving the higher-dose combination losing 24.8 lbs (11.3%)
Side effect Some possible side effects of IGF-1 LR3 may include the following: muscle and joint pain, nausea, headaches, hypoglycemia (usually when IGF-1 LR3 is administered in continuous high doses) and may be associated with increased risk of developing some cancers
Call us today at 703-988-2000 to book your free yes, free consultation, and find out how we can help you achieve your dream body!
Some people see dramatic improvement in insulin sensitivity, triglycerides, and inflammatory markers even before significant weight loss occurs